444 related articles for article (PubMed ID: 25983763)
1. The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.
Wu L; Jin C; Bai S; Davies H; Rao H; Liang Y; Wu N
J Res Med Sci; 2015 Feb; 20(2):127-32. PubMed ID: 25983763
[TBL] [Abstract][Full Text] [Related]
2. [Highly active antiretroviral therapy on liver function in HIV-positive children with HBV/HCV co-infection].
Wu LJ; Jin CZ; Bai S; Liang Y; Wu NP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):180-6. PubMed ID: 24782375
[TBL] [Abstract][Full Text] [Related]
3. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
4. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
5. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
[TBL] [Abstract][Full Text] [Related]
6. The Effect of HBV/HCV in Response to HAART in HIV Patients after 12 Months in Kumba Health District in the South West Region of Cameroon.
Ndifontiayong AN; Ali IM; Sokoudjou JB; Ndimumeh JM; Tume CB
Trop Med Infect Dis; 2021 Aug; 6(3):. PubMed ID: 34449737
[TBL] [Abstract][Full Text] [Related]
7. [The influence of human immunodeficiency virus co-infection with hepatitis C virus and hepatitis B virus on the efficacy of high active anti-retroviral therapy].
Li XF; Kan QC; He Y; Yu ZJ; Li ZQ; Liang HX
Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):951-4. PubMed ID: 21211210
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
[TBL] [Abstract][Full Text] [Related]
9. Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.
Li ZC; Li HJ; Dai LL; Gao YQ; Cai WP; Li HY; Huang XJ; Zhang T; Wu H
Chin Med J (Engl); 2010 Dec; 123(24):3587-90. PubMed ID: 22166636
[TBL] [Abstract][Full Text] [Related]
10. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study.
Ranin J; Salemovic D; Brmbolic B; Marinkovic J; Boricic I; Pesic PI; Zerjav S; Stanojevic M; Jevtovic D
Curr HIV Res; 2018; 16(3):222-230. PubMed ID: 30014804
[TBL] [Abstract][Full Text] [Related]
12. Effect of Hepatitis B Virus Co-Infection on CD4 Cell Count and Liver Function of HIV Infected Patients.
Olawumi HO; Olanrewaju DO; Shittu AO; Durotoye IA; Akande AA; Nyamngee A
Ghana Med J; 2015 Mar; 49(1):2-6. PubMed ID: 26339077
[TBL] [Abstract][Full Text] [Related]
13. Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients.
Olawumi HO; Olanrewaju DO; Shittu AO; Durotoye IA; Akande AA; Nyamngee A
Ghana Med J; 2014 Jun; 48(2):96-100. PubMed ID: 25667557
[TBL] [Abstract][Full Text] [Related]
14. Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.
Puri P; Sharma PK; Lolusare A; Sashindran VK; Shrivastava S; Nagpal AK
J Clin Exp Hepatol; 2017 Mar; 7(1):1-8. PubMed ID: 28348464
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.
Audsley J; Seaberg EC; Sasadeusz J; Matthews GV; Avihingsanon A; Ruxrungtham K; Fairley K; Finlayson R; Hwang HS; Littlejohn M; Locarnini S; Dore GJ; Thio CL; Lewin SR
PLoS One; 2011; 6(11):e26482. PubMed ID: 22069454
[TBL] [Abstract][Full Text] [Related]
16. Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia.
Nie Y; Lan Y; Deng XZ; Li LH; Cai WP; Li F; Hu FY
Infect Genet Evol; 2020 Oct; 84():104480. PubMed ID: 32736042
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
den Brinker M; Wit FW; Wertheim-van Dillen PM; Jurriaans S; Weel J; van Leeuwen R; Pakker NG; Reiss P; Danner SA; Weverling GJ; Lange JM
AIDS; 2000 Dec; 14(18):2895-902. PubMed ID: 11153671
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
19. Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically co-infected individuals.
Kottilil S; Jagannatha S; Lu A; Liu S; McLaughlin M; Metcalf JA; Dewar R; Campbell C; Koratich C; Maldarelli F; Masur H; Polis MA
HIV Clin Trials; 2004; 5(1):25-32. PubMed ID: 15002084
[TBL] [Abstract][Full Text] [Related]
20. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
